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ABSTRACT 
Now-a-days, the emphasis of pharmaceutical researchers is turned towards the development of more efficacious drug delivery systems with already 
existing molecule. However, in recent applications, Multiparticulate drug delivery systems (MDDS) are gaining much favor over single- unit dosage 
forms because of their potential benefits like predictable gastric emptying, least risk of dose dumping, flexible release pattern and increased 
bioavailability with minimum inter- and intra- subject variability. The advances in such drug delivery systems have simultaneously urged the 
discovery of novel excipients which are safe and fulfill specific functions and directly or indirectly influence the rate and extent of release and/or 
absorption. The plant derived gums and mucilages comply with many requirements of pharmaceutical excipients as they are non-toxic, stable, easily 
available, associated with less regulatory issues as compared to their synthetic counterpart and inexpensive; also these can be easily modified to 
meet the specific need. The pharmaceutical scientists have achieved a great success in developing most therapeutic systems with suitable natural 
polymer. The current article focuses on the merits, limitations, types of MDDS and application of natural polymer as drug release retardant material 
for MDDS with supportive studies on natural polymer and MDDS currently available in the market. 
Keywords: Multiparticulate drug delivery systems, Natural polymers, Drug release retardant materials, Gums, Mucilages, Polysaccharides. 
 
INTRODUCTION 
Drug Delivery Systems (DDS) is a strategic tool for expanding 
markets/indications, extending product life cycles and generating 
opportunities. DDS make a significant contribution to global 
pharmaceutical sales through market segmentation, and are moving 
rapidly. Drug delivery systems are becoming increasingly 
sophisticated as pharmaceutical scientists acquire a better 
understanding of the physicochemical and biochemical parameters 
pertinent to their performance [1]. 
Despite of tremendous advancements in drug delivery, 
multiparticulate oral dosage forms acquired a centre stage in the 
arena of pharmaceutical research and development for achieving the 
delayed release oral formulations; thus provide tremendous 
opportunities and extending the frontier of future pharmaceutical 
development. These formulations release the drug at a time rather 
than promptly after administration, offers design flexibility and 
clinical benefits than single units such as short gastric residence 
time, most patient convenience means of drug administration, 
maximum drug absorption, reduce peak plasma fluctuations, 
minimize the potential side effects due to dose dumping and 
numerous technological, therapeutical advantages over single- unit 
forms [2]. Multiparticulate drug delivery systems (MDDS), mostly 
used for an oral route, consist of the multiplicity of small discrete 
units that exhibit different characteristics. Together, these 
characteristic units provide the overall desired controlled release of 
the dose. It is based on subunits such as granules, beads, 
microspheres, pellets, spheroids and Minitab. In MDDS, drug 
substances are divided into number of subunits, typically consist of 
thousands of spherical particles having diameter of about 0.05-2.00 
mm. To administer or to recommend total dose these subunits are 
compressed into a tablet or filled into a sachet or encapsulated [3]. 
Multiparticulates may be prepared by several methods. Different 
methods require different processing conditions and produce 
multiparticulates of distinct qualities. Some of these methods may be 
broadly classified as pelletization, granulation, spray drying, and 
spray congealing. Drug particles may be entrapped within the 
multiparticulates or layered around them. Subsequently, these 
multiparticulates may be modified in many ways to achieve the 
desired drug release profile. One approach to the modification of 
drug release profile in multiparticulates is to coat them. Reasons for 
application of coating onto multiparticulates are to obtain functional 
coats, provide chemical stability, improve physical characteristics 
and enhance patient acceptance. Coats are formed from various 
polymeric coating materials broadly classified as aqueous polymer 
dispersions, polymer solutions, molten polymers and dry powders. 
Depending on the type of coating material used, functions such as 
sustained release (SR), targeted release, delayed release, and 
pulsatile release can be achieved [4]. 
Merits of MDDS 
This type of drug delivery has been at the centre of research due to 
its many benefits over conventional dosage forms, some of which 
are as follows:  
• Predictable, reproducible and short gastric residence time 
• Less inter- and intra-subject variability 
• Improve bioavailability 
• Reduced adverse effects and improved tolerability 
• Limited risk of local irritation  
• No risk of dose dumping 
• Flexibility in design 
• Ease of combining pellets with unlike compositions or release 
patterns 
• Improve stability 
• Improve patient comfort and compliance 
• Achieve a unique release pattern 
• Extend patent protection, globalize product and overcome 
competition[5]. 
Limitations of MDDS 
Multiparticulate drug delivery systems like other delivery systems 
have several limitations. These include 
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• Several formulation steps  
• Higher cost of production 
• Low drug loading 
• Require advanced technology 
• Proportionally higher need for excipients 
• Lack of manufacturing reproducibility and efficacy 
• Large number of process variables 
• Trained/skilled individual needed for manufacturing [6]. 
Types of MDDS 
There are different types of MDDS based on the drug release 
mechanism and these are enumerated and explained below. 
I. Reservoir coated systems 
II. Matrix coated systems 
III. Specialized systems [7]. 
 
Fig. 1: Schematic representation of typical release mechanism [8] 
 
Reservoir coated systems 
Such systems consist of a drug layered core surrounded by a 
polymer. The mechanism of controlling the drug release from 
reservoir type systems is often complex and depends on coating 
type, thickness, drug type and core type. Those mechanisms include 
• Diffusion through the continuous polymer film surrounding the 
drug loaded core. Firstly, water penetrates through the coating until 
reaches the pellet core. Afterwards, drug is dissolved and released 
due to the concentration gradient inside the pellet versus outside 
the pellet [Fig. 1(A)]. 
• Drug release can occur through water filled pores. These pores 
can be due to leaching of water soluble compounds into the release 
medium or due to cracks formed by high hydrostatic pressure 
generated inside these systems upon water uptake [Fig.1 (B & C)]. 
• For this mechanism to occur an osmotic active core is 
surrounded by semi-permeable membrane. Upon water uptake and 
under right circumstances, an osmotic pressure is built up within the 
interior of the core and the drug is pushed out via pores in the 
coating [Fig.1(C)] [9]. 
Matrix coated systems 
In these systems a polymer: drug solution or dispersion is sprayed 
onto pellets in order to achieve controlled drug release. The drug 
and polymer are dissolved or dispersed in a common solvent and 
upon solvent evaporation, a solid solution (drug dissolved in the 
polymer) or a solid dispersion (drug dispersed in the polymer) or a 
combination of both is obtained. If the initial drug concentration is 
below drug solubility in the polymer, drug is dissolved and drug 
release is mainly controlled by drug diffusivity in the polymer [10]. 
Specialized systems 
These MDDS can be specially designed into various types. 
• Pulsatile system based on rupturable coating: This is a 
multiparticulate system in which the drug is coated onto the non-
pareil sugar seeds followed by a swell able layer and an insoluble 
top layer. The release is independent of environmental factors like 
pH and drug solubility. The lag time can be varied by varying coating 
thickness or adding high amounts of lipophilic plasticizer in the 
outermost layer. 
• Low density floating multiparticulate pulsatile systems: 
These systems reside only in the stomach and not affected by 
variability of pH local environment or gastric emptying rate. These 
are advantageous for drugs either absorbed from the stomach or 
requiring local delivery in stomach.  
• Time controlled expulsion systems: This system is based on a 
combination of osmotic and swelling effects. The core contains the 
drug, a low density solid and/or liquid lipid material and a 
disintegrant. The core is further coated with cellulose acetate. 
• Sigmoidal release system: This consists of pellet cores 
comprising drug and succinic acid coated with ammonia-
methacrylate copolymer USP/NF type B. The time lag is controlled 
by the rate of water influx through the polymer membrane. The 
water dissolves acid and the drug in the core. The acid solution in 
turn increases permeability of the hydrated polymer film [11]. 
 
Table 1: Examples of marketed MDDS [12, 13] 
Product Company Drug Release 
Losec MUPS AstraZeneca Omeprazole magnesium Delayed release multiple unit pellet system in tablet 
Nexium AstraZeneca Esomeprazole magnesium Enteric delayed release pellets in capsule 
Toprol XL AstraZeneca Metaprolol succinate Controlled release pellets in capsule 
Avinza King Morphine sulfate QD/IR+SR layered beads in capsule 
SoluTab Takeda Lansoprazole Delayed release enteric coated microgranules in tablet 
Prevacid Takeda Lansoprazole Delayed release enteric coated granules in capsule 
Coreg CR GSK  Carvedilol phosphate QD/IR+SR polymer coated beads in capsule 
InnoPran XL GSK  Propranolol Hcl QD / Delayed release SR coated beads in capsule 
Spansule GSK  d-amphetamine sulfate QD/IR+SR coated beads in capsule 
Focalin XR Novartis Dexmethylphenidate QD / Bi-modal pulsatile release IR+Enteric delayed release beads 
in capsule 
Adderall XL Shire  Mixed salts of a single entity amphetamine QD /double pulse drug layered and SR polymer coated beads 
Carbatrol Shire  Carbamazepine BID / IR+SR+Enteric beads in capsule 
Equetro ER Validus Carbamazepine BID / IR+SR+Enteric beads in capsule 
Metadate CD UCD, Inc. Methylphenidate QD /30%IR + 70% SR coated beads 
Pentasa Shire Mesalamine Controlled release beads in capsule 
Luvox CR Jazz Fluvoxamine maleate QD / polymer coated beads in capsule 
Amrix Cephalon Cyclobenzaprine Hcl QD/ polymer coated beads in capsule 
 
 
Natural polymers as release retarding material for MDDS 
Extensive applications of polymers in drug delivery have been 
realized because polymers offer unique properties which have not 
been attained by any other materials. Polymers have been 
successfully investigated and employed in the formulation of solid, 
liquid and semi-solid dosage forms and are specifically useful in the 
design of novel drug delivery systems. Pharmaceutical polymers are 
widely used to achieve taste masking; controlled release (e.g. 
extended, pulsatile and targeted) enhanced stability and improved 
bioavailability [14, 15]. Polymers which are used as release 
retarding materials in the design of sustained and controlled release 
drug delivery systems play a vital role in controlling the delivery of 
the drug from these systems. The success of modified drug delivery 
system depends on how well the polymer regulates the release of 
drug from the systems. Though a wide range of release retarding 
polymers are available, there is a continued need to develop new 
and more efficient release - retarding polymers for sustained and 
controlled release [16, 17]. 
Today, the whole world is increasingly interested in natural drugs 
and excipients. Continued improvement and accelerating research 
and development in polymeric materials has played a vital role in 
the progress of most controlled release technologies. In the past 25 
years, there has been a considerable increase in interest in this 
technology, as is shown by the increasing number of publications 
and patents in the area of controlled drug-release systems using 
synthetic as well as naturally occurring polymeric materials [18]. 
Both synthetic and natural polymers have been investigated 
extensively for this purpose. Synthetic polymers are toxic, expensive, 
have environment related issues, need long development time for 
synthesis and are freely available in comparison to naturally 
available polymers. Ability to produce a wide range of material 
based on their properties and molecular weight. Natural polymers 
became a thrust area in the majority of investigations in drug [19]. 
With the availability of variety of natural polymers, the 
manufacturers today have a great success in developing the most 
promising therapeutic systems, namely drug delivery system, which 
provides an effective therapy to patients for prolonged periods [20]. 
The release behavior of drug from the formulation containing 
natural polymers depends on the physicochemical properties of 
both the drug and polymer. Release pattern of polymer, morphology, 
particle size, size and shape of dosage form are some of factors that 
influence the release of drug. Natural polymers, gums and mucilages 
modify the drug release from formulation [21]. 
Natural gums and mucilages are preferred over semi-synthetic and 
synthetic excipients in the field of drug delivery because they are 
cheap and easily available, have soothing action and nonirritant 
nature. Further, they are eco-friendly, capable of multitude of 
chemical modifications, potentially degradable and compatible due 
to their natural origin [22]. It should be noted that many “old” 
materials compete successfully today after almost a century of 
efforts to replace them. It is the usual balance of economics and 
performance that determines the commercial realities. Natural gums 
are among the most popular hydrophilic polymers because of their 
cost effectiveness and regulatory acceptance [23]. Natural gums 
have been modified to overcome certain drawbacks like 
uncontrolled rate of hydration, thickening, drop in viscosity on 
storage, microbial contamination etc [24]. Different natural gums 
have been used to design oral controlled release multi particulate 
dosage forms such as microspheres are becoming more popular 
single unit dosage forms [25]. In several cases, the polysaccharides, 
resins or the tannins present in the gum are responsible for 
imparting release retardant properties to the dosage form [26]. 
Among hydrophilic polymers, polysaccharides which are relatively 
complex carbohydrates are the choice material due to their non 
toxicity. Being natural they have certain drawbacks like purity, 
source and microbial contamination. If these factors can be 
identified and controlled, polysaccharides can be good substitute for 
synthetic polymer [27]. The specific application of natural 
polysaccharide polymers in pharmaceutical formulations include to 
aid in the processing of the drug delivery system during its 
manufacture, protect, support or enhance stability, bioavailability or 
patient acceptability, assist in product identification, or enhance any 
other attribute of the overall safety, effectiveness or delivery of the 
drug during storage or use [26]. Natural polysaccharides are often 
incorporated in the design of controlled drug delivery such as those 
target delivery of the drug to a specific site in the gastro intestinal 
tract (GIT), this can be achieved by various mechanisms including 
coating granules, pellets, tablets with polysaccharides having pH 
dependent solubility, or incorporating non-digestible 
polysaccharides that are degraded by bacterial enzymes present in 
the colon, this property makes these polysaccharides potentially 
useful in the formulation of colon-targeted drug delivery systems 
[28]. 
The review highlights the literatures related to the research made 
on plant based novel drug release-retarding materials which have 
been recently studied as carriers not only in the conventional 
sustained release dosage forms but also in chronotherapeutic drug 
delivery systems, gastro retentive systems, colonic drug delivery 
systems and microspheres. Specific reference thus is made to the use 
of natural polymers in the design of multiparticulate drug delivery 
systems as well as other new drug delivery systems under 
investigation. 
Raju Onkar Sonawane, et al., developed extended release matrix 
pellets by using Lornoxicam as a model drug for prolong release of 
drug for an extended period of time after predetermined lag time for 
the chronotherapy of rheumatoid arthritis. The pellets were 
prepared by the Extrusion and Spheronization method using release 
retarding polymers like xanthan gum, xyloglucan and in combination 
with PVP K-30 and MCC PH-101 as pelletization aid. The effects of 
various formulation variables on the size and drug release were 
investigated. Matrix pellets containing 30% xanthan gum (XG), 30% 
of xyloglucan (Xg) and 30% combination of XG: Xg showed sustained 
release of lornoxicam for15 h [29]. 
Kamat Akshay Ramesh, et al., formulated an oral pulsatile drug 
delivery system using natural superdisintegrants and natural 
polymers to achieve the time release of Indomethacin, based on 
chronopharmaceutical approach for the treatment of rheumatoid 
arthritis. The press-coated pulsatile release tablet contains 
Indomethacin in the inner rapid release core tablet formulated by 
direct compression method using Plantago ovata mucilage and 
modified agar as superdisintegrants and the external coat was 
formulated using natural polymers such as dammar gum, chitosan, 
xanthan gum and guar gum by both direct and wet granulation 
method. In-vitro release profiles of pulsatile device during 10 h 
studies were found to have very good sustaining efficacy. 
Formulation B2 containing xanthan gum and dammar gum in the 
ratio of 2:1 having maximum lag time of 7h 15 min [30]. 
Sarojini Sarangapani,et al., prepared gastro retentive tablets of 
Lansoprazole. Gel-forming polymer HPMC K4M, natural polymer 
and gas-generating agent sodium bicarbonate were added to the 
drug to achieve in vitro buoyancy. The In-vitro release of the 
formulation F1and F2 (synthetic polymer) showed more drug 
release and F7 and F8 (natural polymer) also showed better 
sustained release properties than synthetic polymer. From the 
results of sustained release properties, it had been concluded that 
the novel natural polymeric material from Delonix regia may be 
natural and economical alternative for the formulation of floating 
drug delivery system. Since Delonix regia gum is of natural origin it 
is non-toxic, biocompatible and cheaper [31]. 
Dharmaraj sinh Chauhan, et al., carried out studies on colon specific 
matrices of Mebeverine HCl using various polysaccharides like guar 
gum, Locust bean gum and xanthan gum by direct compression 
method. Swelling studies indicated that, matrix tablets prepared 
with xanthan gum, XG (X4) swelled more as compared to those 
prepared using guar gum, GG and locust bean gum, LBG. Release 
profiles indicated that, increase in the polymer concentration has 
drastically retarded the release of Mebeverine Hcl. The optimized 
tablets prepared using GG (G4), LG (L4) & XG (X4) showed 
controlled release over periods of 24 hrs, whereas the marketed 
product controlled the drug release over a period of 12 hrs. The 
mechanism of drug release was Non-Fickian diffusion controlled 
first order kinetics for optimized matrix tablets of GG (G4) and LBG 
Doniparthi et al. 
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(L4), whereas for XG (X4) it followed Highuchi model. The developed 
matrix tablets can be viewed as a better approach in the colonic 
delivery of Mebeverine HCl [32]. 
Nagamani Bolla, et al., employed microencapsulation for oral use to 
sustain the drug release, and to reduce or eliminate gastrointestinal 
irritation. Irbesartan loaded microspheres were prepared using 
gelatin as a base material along with kernel powder (Tamarindus 
indica belonging to family Fabaceae) and acacia by phase separation 
and Coacervation method. Kernel powder loaded microspheres has 
shown better control over drug release than acacia. Microspheres 
shown lowered bursting effect and controlled release rate. The size 
and compatibility of microspheres were analyzed by using SEM and 
FTIR respectively. This was the first report on kernel powder which is 
obtained from Tamarind seeds used as a control releasing agent [33]. 
Gandhi, et al., developed a multiparticulate system intended to 
utilize natural material for controlled drug delivery system. The 
system comprising of Cashew Gum coated pellets, designed for 
controlled drug delivery of Diltiazem hydrochloride. The sugar 
beads/pellets were loaded with drug (Diltiazem hydrochloride) 
using microcrystalline cellulose as a spheronizing aid and PVP K30 
as a binder. Different coat weights of Cashew Gum were applied to 
the drug loaded pellets in Fluidized Bed Processor (FBP) to 
produce the controlled release drug delivery. In-vitro dissolution 
studies of the pellets performed which showed that the drug 
release from the coated pellets depends on the coat weights 
applied. Since, Diltiazem hydrochloride is a drug, which exhibits a 
high solubility, it would be possible to minimize drug release from 
coated pellets and effectively release the drug for controlled drug 
delivery system [34]. 
 
Table 2: Literature review on application of Natural Polymers used in Sustained Release Tablets 
Natural polymer Model drug Results Ref 
Seed powder of  Strychnos 
potatorum 
Diclofenac sodium Seed powder when used at a concentration of 40% was capable of sustaining the 
release of drug up to 10 hrs. Further, purification of seed powder may improve its 
release retardant properties. 
[17] 
Tamarind seed polysaccharide Metformin 
Hydrochloride 
Tamarind gum polysaccharide being a natural polysaccharide can be administered 
to patients safely, thereby improving the patient compliance by releasing the drug 
in a sustained manner. 
[22] 
Mucilage of  Aloe barbadensis 
miller 
Glimepiride Dried Aloe barbadensis miller mucilage and Povidone combination could be used as 
a matrix forming material for making Sustained release matrix tablets. 
[35] 
Resin of  Artocarpus 
hetrophyllus (Jackfruit latex)  
Theophylline It was found that 10% of processed jack fruit latex powder was required for 
optimum drug release profile of sustained release tablets of theophylline. 
[36] 
Seed mucilage of  Vigna mungo 
(Black gram) 
Aceclofenac The mucilage powder with the maximum concentration of 10 % w/w showed 
sustained drug release of 29.43 % at the end of 8h showing good sustained release 
and matrix forming capacity 
[37] 
 Natural mucilage of 
Abelmoschus esculentus (Okra 
gum)   
Diclofenac sodium Sustained release matrix of the mucilage at 10-15% concentration was capable of 
prolonging the release of drug for 10 hrs. 
[38] 
Mucilage of Hibiscus 
rosasinensis Linn 
Diclofenac sodium The dried mucilage can be used as release-retarding agent for 12 h when the drug-
mucilage ratio was 1:1.5. 
[39] 
 Myrrh oleo gum resin (MOGR) Domperidone The results clearly specify the potential of MOGR could be used as binder, release 
retardant and mucoadhesive natural material in tablet formulations. 
[40] 
Seed mucilage of Ocimum 
tenuiflorum Linn 
DiltiazemHCl It was founded the seed mucilage alone does not give the desired release retardant 




The market for drug delivery system has come a long way and will 
continue to grow at an impressive rate. Today’s drug delivery 
technologies enable the incorporation of drug molecules into a new 
delivery system, thus providing numerous therapeutic and 
commercial advantages. Present scenario of MDDS; find a greater 
advantage due to its flexible design in variable release properties, 
stability and patient compliance. Drug release retarding polymers are 
the key performers in controlling the release of drug from the systems 
for which natural polymers play an important role. Natural materials 
being readily available, cost effective, eco-friendly, biodegradable and 
biocompatible due to their natural origin can be extensively used in 
the field of drug delivery. In recent years, the interest is growing to 
develop multiparticulate drug delivery system with the use of natural 
polymer thereby increasing the therapeutic value as well as reducing 
toxicity. The approaches in this article represent application of natural 
polymers as drug release retardant material with a view to design 
multiparticulate drug delivery systems keeping in mind the toxic 
effects of the drugs incorporated and to maintain the overall stability 
of the product on the account of the properties of natural polymers. 
Thus MDDS with natural polymers as drug release retardant material 
should be promising in the future. 
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